Results 21 to 30 of about 50,400 (305)

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

Neurology, 2020
The prodromal phase of dementia with Lewy bodies (DLB) includes (1) mild cognitive impairment (MCI), (2) delirium-onset, and (3) psychiatric-onset presentations.
I. McKeith, T. Ferman, Alan J. Thomas, F. Blanc, B. Boeve, H. Fujishiro, K. Kantarci, C. Muscio, J. O'Brien, R. Postuma, D. Aarsland, C. Ballard, L. Bonanni, P. Donaghy, M. Emre, J. Galvin, D. Galasko, J. Goldman, S. Gomperts, L. Honig, M. Ikeda, J. Leverenz, S. Lewis, K. Marder, M. Masellis, D. Salmon, John-Paul Taylor, D. Tsuang, Z. Walker, P. Tiraboschi   +29 more
semanticscholar   +1 more source

Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer’s disease

Brain : a journal of neurology, 2021
Patients who have dementia with Lewy bodies and Alzheimer’s disease show early degeneration of the cholinergic nucleus basalis of Meynert. However, how white matter projections between the nucleus basalis of Meynert and the cortex are altered in ...
J. Schumacher, Nicola J. Ray, C. Hamilton, P. Donaghy, M. Firbank, G. Roberts, L. Allan, R. Durcan, Nicola Barnett, J. O'Brien, John-Paul Taylor, Alan J. Thomas   +11 more
semanticscholar   +1 more source

Dementia with Lewy bodies - a disease from the border of Neurology and Psychiatry - case report

Journal of Education, Health and Sport, 2017
This article presents the case of 88 years old patient diagnosed and treated for dementia with Lewy bodies.
Lukasz Kroc, Aleksandra Szczepkowska
doaj   +3 more sources

Retraction Note: Brain-derived exosomes from dementia with lewy bodies propagate α-synuclein pathology. [PDF]

Acta Neuropathol Commun
Ngolab J, Trinh I, Rockenstein E, Mante M, Florio J, Trejo M, Masliah D, Adame A, Masliah E, Rissman RA.   +9 more
europepmc   +3 more sources

Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies

Brain Communications, 2021
In patients with suspected dementia with Lewy bodies, the detection of the disease-associated α-synuclein in easily accessible tissues amenable to be collected using minimally invasive procedures remains a major diagnostic challenge.
D. Perra, M. Bongianni, G. Novi, Francesco Janes, Valentina Bessi, S. Capaldi, Luca Sacchetto, M. Tagliapietra, G. Schenone, S. Morbelli, M. Fiorini, Tatiana Cattaruzza, Giulia Mazzon, C. Orrú, M. Catalan, P. Polverino, A. Bernardini, Gaia Pellitteri, M. Valente, Claudio Bertolotti, B. Nacmias, G. Maggiore, T. Cavallaro, P. Manganotti, G. Gigli, S. Monaco, F. Nobili, G. Zanusso   +27 more
semanticscholar   +1 more source

Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium

Frontiers in Neurology, 2022
The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and ...
Gregory D. Scott, Gregory D. Scott, Moriah R. Arnold, Thomas G. Beach, Christopher H. Gibbons, Anumantha G. Kanthasamy, Russell M. Lebovitz, Afina W. Lemstra, Leslie M. Shaw, Charlotte E. Teunissen, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Henrik Zetterberg, Angela S. Taylor, Todd C. Graham, Bradley F. Boeve, Stephen N. Gomperts, Neill R. Graff-Radford, Charbel Moussa, Kathleen L. Poston, Liana S. Rosenthal, Marwan N. Sabbagh, Ryan R. Walsh, Miriam T. Weber, Melissa J. Armstrong, Jee A. Bang, Andrea C. Bozoki, Kimiko Domoto-Reilly, John E. Duda, John E. Duda, Jori E. Fleisher, Douglas R. Galasko, James E. Galvin, Jennifer G. Goldman, Samantha K. Holden, Lawrence S. Honig, Daniel E. Huddleston, James B. Leverenz, Irene Litvan, Carol A. Manning, Karen S. Marder, Alexander Y. Pantelyat, Victoria S. Pelak, Douglas W. Scharre, Sharon J. Sha, Holly A. Shill, Zoltan Mari, Joseph F. Quinn, Joseph F. Quinn, David J. Irwin, David J. Irwin, David J. Irwin, David J. Irwin   +54 more
doaj   +1 more source

The temporal onset of the core features in dementia with Lewy bodies

Alzheimer's & Dementia, 2021
We examined the temporal sequence of the core features in probable dementia with Lewy bodies (DLB).
Parichita Choudhury, J. Graff‐Radford, J. Aakre, Lincoln I. Wurtz, D. Knopman, N. Graff-Radford, K. Kantarci, L. Forsberg, J. Fields, Otto Pedraza, Qin Chen, T. Miyagawa, G. Day, P. Tipton, R. Savica, H. Botha, Christian Lachner, B. Dredla, R. Reichard, R. C. Petersen, Dennis W. Dickson, B. Boeve, T. Ferman   +22 more
semanticscholar   +1 more source

Advances in dementia with Lewy bodies

Therapeutic Advances in Neurological Disorders, 2021
Dementia with Lewy bodies (DLB) is a clinical diagnosis representing a specific presentation of a pathological α-synucleinopathy (Lewy body disease). DLB is one entity under the broader term Lewy body dementia , which also includes Parkinson’s disease ...
Melissa J. Armstrong
doaj   +1 more source

Diagnosis and management of dementia with Lewy bodies

Neurology, 2017
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade.
I. McKeith, B. Boeve, D. Dickson, G. Halliday, John-Paul Taylor, D. Weintraub, D. Aarsland, J. Galvin, J. Attems, C. Ballard, Ashley Bayston, T. Beach, F. Blanc, N. Bohnen, L. Bonanni, J. Bras, P. Brundin, D. Burn, A. Chen-Plotkin, J. Duda, O. El‐Agnaf, H. Feldman, T. Ferman, D. Ffytche, H. Fujishiro, D. Galasko, J. Goldman, S. Gomperts, N. Graff-Radford, Lawrence S. Honig, Á. Iranzo, K. Kantarci, D. Kaufer, W. Kukull, V. Lee, J. Leverenz, S. Lewis, C. Lippa, A. Lunde, M. Masellis, E. Masliah, P. McLean, B. Mollenhauer, T. Montine, E. Moreno, E. Mori, Melissa M Murray, J. O'Brien, Sotoshi Orimo, R. Postuma, S. Ramaswamy, O. Ross, D. Salmon, A. Singleton, Angela S. Taylor, Alan J. Thomas, P. Tiraboschi, J. Toledo, J. Trojanowski, D. Tsuang, Z. Walker, M. Yamada, K. Kosaka   +62 more
semanticscholar   +1 more source

A new visual rating scale for Ioflupane imaging in Lewy body disease

NeuroImage: Clinical, 2018
Background: Dopaminergic loss on 123I-Ioflupane brain imaging is a recognised biomarker for dementia with Lewy bodies. It is usually assessed using a visual rating scale developed for Parkinson's disease, which may not be optimal for dementia with Lewy ...
Jim J. Lloyd, George Petrides, Paul C. Donaghy, Sean J. Colloby, Johannes Attems, John T. O'Brien, Gemma Roberts, Alan J. Thomas   +7 more
doaj   +1 more source